Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia.
Curr Opin Urol. 2021 Jul 1;31(4):346-353. doi: 10.1097/MOU.0000000000000886.
Male infertility has been shown to be associated with different maladies. The present systematic review and meta-analysis aimed to summarize the available evidence on the association between male infertility or childlessness and prostate cancer.
The PubMed, Web of Science, and Scopus databases were searched according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses statement. Studies were deemed eligible if they compared males with known infertility or childlessness to the control group including fertile males with regards to the diagnosis of prostate cancer. Overall, ten studies met our eligibility criteria. Three studies found that infertility was associated with higher risk of prostate cancer, four studies - with a reduced risk of prostate cancer, and three studies found no association. The forest plot revealed that infertility was not associated with prostate cancer (odds ratio [OR]: 1.26, 95% confidence interval [CI] 0.63-2.54; P = 0.5). Infertility was not associated with high (OR: 1.44, 95% CI 0.54-3.83; P = 0.5) or low (OR: 0.99, 95% CI 0.43-2.27; P = 0.9) grade prostate cancer.
Infertility or childlessness were not associated with the risk of prostate cancer. The significant heterogeneity between the included studies supports the need for more granular research to guide/fine tune early detection guidelines based on fertility.
男性不育与多种疾病有关。本系统评价和荟萃分析旨在总结男性不育或不孕与前列腺癌之间关联的现有证据。
根据系统评价和荟萃分析报告的首选报告项目,检索了 PubMed、Web of Science 和 Scopus 数据库。如果研究将已知不育或不孕的男性与包括有生育能力的男性在内的对照组进行比较,以诊断前列腺癌,则认为这些研究符合入选标准。共有 10 项研究符合我们的入选标准。有 3 项研究表明不育与前列腺癌风险增加相关,4 项研究表明不育与前列腺癌风险降低相关,3 项研究未发现相关性。森林图显示不育与前列腺癌无关(比值比 [OR]:1.26,95%置信区间 [CI] 0.63-2.54;P=0.5)。不育与高(OR:1.44,95%CI 0.54-3.83;P=0.5)或低(OR:0.99,95%CI 0.43-2.27;P=0.9)分级前列腺癌无关。
不育或不孕与前列腺癌风险无关。纳入研究之间存在显著的异质性,支持需要更精细的研究,以便根据生育能力指导/微调早期检测指南。